Work

A phase 2 study of the insulin‐like growth factor‐1 receptor inhibitor MK‐0646 in patients with metastatic, well‐differentiated neuroendocrine tumors

Year: 2012

Type: article

Study design: Clinical Trial

Source: Cancer

DOI: 10.1002/cncr.27459

Authors: Diane L. Reidy‐Lagunes, Efsevia Vakiani, Michal F. Segal, Ellen M. Hollywood, Laura H. Tang, David B. Solit, M. Catherine Pietanza, Marinela Capanu, Leonard B. Saltz

Institution: Memorial Sloan Kettering Cancer Center

Language: English

Topic: Neuroendocrine Tumor Research Advances

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2077074120

FWCI: 5.195

Cites: 21

Cited by: 64

Related to: 10